Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.
Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Hum Vaccin Immunother. 2023 Aug 1;19(2):2245720. doi: 10.1080/21645515.2023.2245720.
Despite widespread availability of vaccines against SARS-CoV-2 virus, the cause of Coronavirus Disease 2019 (COVID-19), its uptake in many Arab countries is relatively low. This literature review aimed to scope evidence on COVID-19 vaccine hesitancy (VH) in the Arab world. A total of 134 articles reporting prevalence of COVID-19 VH and associated factors, conducted in any of the 22 Arab League countries, were reviewed. COVID-19 VH prevalence ranged from 5.4% to 83.0%. Female gender, young age, low education level and lack of previous influenza vaccine uptake were most commonly reported to be associated with COVID-19 VH. The most-reported personal concerns contributing toward VH were related to the rapid development, safety and side effects of vaccine, as well as an overall lack of trust in government policies toward pandemic control and widespread conspiracy theories. Tailored interventions to enable the distribution of trusted information and enhance public acceptance of immunization are warranted.
尽管有广泛的 SARS-CoV-2 病毒疫苗(导致 2019 年冠状病毒病,COVID-19),但其在许多阿拉伯国家的接种率相对较低。本文献综述旨在概述阿拉伯世界 COVID-19 疫苗犹豫(VH)的证据。共审查了在阿拉伯联盟 22 个国家中的任何一个国家进行的 134 篇报告 COVID-19 VH 及相关因素流行率的文章。COVID-19 VH 的流行率范围为 5.4%至 83.0%。女性、年轻、低教育程度和缺乏以前接种流感疫苗是与 COVID-19 VH 最常相关的因素。报告最多的个人关注因素与疫苗的快速发展、安全性和副作用有关,以及对政府大流行控制政策和广泛的阴谋论的普遍缺乏信任。需要有针对性的干预措施来传播可信信息,并增强公众对免疫接种的接受程度。